IU Ventures — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Kovina Therapeuticskovina.cominJun 2021
Kovina develops first-in-class small molecule antiviral drugs to treat HPV-induced cancers and premalignant infections such as cervical and anal dysplasia.
BiotechHealthtechIndianapolis, US
William Ringo(Director)Elliot Androphy(Chief Scientific Officer)Teri Willey(Director)Fritz French(Chairman of the Board)Kristin Sherman(Chief Executive Officer, President and Treasurer)Susan Mahony(Director)
Stagetimestagetime.comSep 2021
Bloomington, US
Jennie Moser(Executive Officer, Director)Scott Eisen(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.